PURPOSE: Adiponectin is a promising biomarker linking obesity and disease risk; however, limited data are available regarding adiponectin in black women among whom obesity is highly prevalent. METHODS: A cross-sectional analysis was conducted to assess racial differences and correlates of serum adiponectin measured in 996 black and 996 white women enrolled in the Southern Community Cohort Study through Community Health Centers in 12 southeastern states from 2002 to 2006. RESULTS: Black subjects had significantly lower adiponectin levels than white subjects (median 10.9 vs 14.9 μg/mL, Wilcoxon p < .0001). Among black subjects, adiponectin was lower among overweight and obese women compared with healthy weight women but showed no clear decreasing trend with increasing severity of obesity; adjusted geometric means (95% confidence interval) were 15.0 [13.8-16.4], 11.5 [10.6-12.5], 9.7 [9.0-10.6], 11.4 [10.3-12.6], and 10.9 [9.5-12.6] μg/mL for body mass index [BMI] categories of 18.5-24.9, 25-29.9, 30-34.9, 35-39.9, and 40-45, p for trend <.0001). In contrast, among whites there was a monotonic reduction in adiponectin over increasing BMI (adjusted geometric means = 19.9 [18.3-21.7], 15.1 [13.9-16.4], 14.3 [13.2-15.5], 12.5 [11.2-13.9], and 11.0 [9.7-12.5] μg/mL, p for trend <.0001). BMI, age, high-density lipoprotein cholesterol, and hypertension were important correlates of adiponectin in both groups. CONCLUSIONS: Among women, racial differences exist in both the magnitude and form of the adiponectin-BMI association.
PURPOSE:Adiponectin is a promising biomarker linking obesity and disease risk; however, limited data are available regarding adiponectin in black women among whom obesity is highly prevalent. METHODS: A cross-sectional analysis was conducted to assess racial differences and correlates of serum adiponectin measured in 996 black and 996 white women enrolled in the Southern Community Cohort Study through Community Health Centers in 12 southeastern states from 2002 to 2006. RESULTS: Black subjects had significantly lower adiponectin levels than white subjects (median 10.9 vs 14.9 μg/mL, Wilcoxon p < .0001). Among black subjects, adiponectin was lower among overweight and obesewomen compared with healthy weight women but showed no clear decreasing trend with increasing severity of obesity; adjusted geometric means (95% confidence interval) were 15.0 [13.8-16.4], 11.5 [10.6-12.5], 9.7 [9.0-10.6], 11.4 [10.3-12.6], and 10.9 [9.5-12.6] μg/mL for body mass index [BMI] categories of 18.5-24.9, 25-29.9, 30-34.9, 35-39.9, and 40-45, p for trend <.0001). In contrast, among whites there was a monotonic reduction in adiponectin over increasing BMI (adjusted geometric means = 19.9 [18.3-21.7], 15.1 [13.9-16.4], 14.3 [13.2-15.5], 12.5 [11.2-13.9], and 11.0 [9.7-12.5] μg/mL, p for trend <.0001). BMI, age, high-density lipoprotein cholesterol, and hypertension were important correlates of adiponectin in both groups. CONCLUSIONS: Among women, racial differences exist in both the magnitude and form of the adiponectin-BMI association.
Authors: Lisa B Signorello; Margaret K Hargreaves; Mark D Steinwandel; Wei Zheng; Qiuyin Cai; David G Schlundt; Maciej S Buchowski; Carolyne W Arnold; Joseph K McLaughlin; William J Blot Journal: J Natl Med Assoc Date: 2005-07 Impact factor: 1.798
Authors: Bruce B Duncan; Maria Inês Schmidt; James S Pankow; Heejung Bang; David Couper; Christie M Ballantyne; Ron C Hoogeveen; Gerardo Heiss Journal: Diabetes Date: 2004-09 Impact factor: 9.461
Authors: James M Shikany; Cora E Lewis; Barry I Freedman; Donna K Arnett; Catherine Leiendecker-Foster; Tamekia L Jones; David T Redden; Albert Oberman Journal: Metabolism Date: 2007-08 Impact factor: 8.694
Authors: Anthony J G Hanley; Donald Bowden; Lynne E Wagenknecht; Aarthi Balasubramanyam; Carl Langfeld; Mohammed F Saad; Jerome I Rotter; Xiuqing Guo; Yii-Der I Chen; Michael Bryer-Ash; Jill M Norris; Steven M Haffner Journal: J Clin Endocrinol Metab Date: 2007-04-10 Impact factor: 5.958
Authors: M S Buchowski; D G Schlundt; M K Hargreaves; J H Hankin; L B Signorello; W J Blot Journal: Cell Mol Biol (Noisy-le-grand) Date: 2003-12 Impact factor: 1.770
Authors: Unab I Khan; Dan Wang; Maryfran R Sowers; Peter Mancuso; Susan A Everson-Rose; Philipp E Scherer; Rachel P Wildman Journal: Metabolism Date: 2012-03-22 Impact factor: 8.694
Authors: Jonathan N Hofmann; Brenda M Birmann; Lauren R Teras; Ruth M Pfeiffer; Ye Wang; Demetrius Albanes; Dalsu Baris; Graham A Colditz; Anneclaire J De Roos; Graham G Giles; H Dean Hosgood; Qing Lan; Ola Landgren; Linda M Liao; Nathaniel Rothman; Stephanie J Weinstein; Michael N Pollak; Marian L Neuhouser; Mark P Purdue Journal: Cancer Res Date: 2016-02-26 Impact factor: 12.701
Authors: Sarah S Cohen; Lisa B Signorello; Elizabeth L Cope; Joseph K McLaughlin; Margaret K Hargreaves; Wei Zheng; William J Blot Journal: Am J Epidemiol Date: 2012-07-20 Impact factor: 4.897
Authors: J L Ebersole; R J Kryscio; C Campbell; D F Kinane; J McDevitt; N Christodoulides; P N Floriano; C S Miller Journal: J Periodontal Res Date: 2016-08-23 Impact factor: 4.419
Authors: Hannah Gardener; Milita Crisby; Charlotte Sjoberg; Barry Hudson; Ronald Goldberg; Armando J Mendez; Clinton B Wright; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco Journal: Metab Syndr Relat Disord Date: 2012-11-05 Impact factor: 1.894
Authors: Abby B Siegel; Abhishek Goyal; Marcela Salomao; Shuang Wang; Valerie Lee; Christine Hsu; Rosa Rodriguez; Dawn L Hershman; Robert S Brown; Alfred I Neugut; Jean Emond; Tomoaki Kato; Benjamin Samstein; David Faleck; Raffi Karagozian Journal: Oncology Date: 2014-10-03 Impact factor: 2.935
Authors: Aseel AlSaleh; Sandra D O'Dell; Gary S Frost; Bruce A Griffin; Julie A Lovegrove; Susan A Jebb; Thomas A B Sanders Journal: Am J Clin Nutr Date: 2011-05-11 Impact factor: 7.045